WIPO
open access
CC BY 4.0
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Implications of the Business Strategies of Pharmaceutical Companies for Industry Developments in Australia#1026056
- Most-Favored-Nation Benchmarking Versus Value-Based Contracting: Institutional Fit of Pharmaceutical Pricing Tools in the United States, Canada, and the United Kingdom.#214049
- (De-)assetizing pharmaceutical patents: Patent contestations behind a blockbuster drug#163638
- Exploring Regulatory Flexibility to Create Novel Incentives to Optimize Drug Discovery#87697
- Impact of China's national drug price negotiation on pharmaceutical firms' innovation activities.#228032
Record · ID 163637
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive